KPV is a tripeptide fragment (Lysine-Proline-Valine) derived from the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH).
🔬 Studied for: Anti-Inflammatory Research
💊 Also studied for: Gut-Inflammation Research
🧪 Not FDA-approved — sold strictly for laboratory research
📈 No standardized human dosage established in published literature
KPV is a tripeptide fragment (Lysine-Proline-Valine) derived from the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH). Research has focused on its anti-inflammatory properties, which appear to be separable from alpha-MSH's pigmentation effects.
KPV is studied for its ability to inhibit NF-kB signaling, a central pathway in the inflammatory response, without requiring activation of melanocortin receptors — a distinction researchers have highlighted as making it useful for isolating anti-inflammatory effects from pigmentation-related ones.
These are effects KPV has been studied for in available preclinical and early research — not claims about guaranteed outcomes.
KPV has been investigated in animal models of colitis and other inflammatory conditions, where researchers have examined its effects on cytokine production and NF-kB pathway activity.
A notable portion of the KPV literature has focused on gastrointestinal inflammation models, an area of overlapping interest with other peptides such as BPC-157 that are also studied for gut-barrier research.
Doses used in preclinical (animal and cell-culture) studies vary by model and are not established as a human protocol. No FDA-approved human dosage exists for KPV.
Compound X does not provide dosing recommendations. KPV is sold for laboratory research use only and is not intended for human consumption.
KPV is not FDA-approved and has not completed large-scale human trials. Comprehensive human safety data does not exist; the peptide's small size and short research history mean available safety information is limited to preclinical models.
No. KPV is not FDA-approved for any indication and is sold strictly as a research chemical, not a medication or dietary supplement.
Anti-Inflammatory Research — KPV has been investigated in animal models of colitis and other inflammatory conditions, where researchers have examined its effects on cytokine production and NF-kB pathway activity.
In the US, UK, Canada and Australia, KPV is generally sold labeled "for research use only, not for human consumption." It is not approved as a dietary supplement or medication in any of these countries.
KPV research is indexed on PubMed under search terms such as "KPV tripeptide anti-inflammatory" and "alpha-MSH fragment NF-kB."
Compare current prices, purity testing claims and coupon codes across every vendor Compound X tracks.
New guides, vendor comparisons and compound breakdowns every week.